In vitro susceptibilities of Rhodococcus equi and other common equine pathogens to azithromycin, clarithromycin, and 20 other antimicrobials

Antimicrobial Agents and Chemotherapy

Volumn 47, Issue 5, 2003, Pages 1742-1745

  Jacks, Stephanie S ^a   Giguère, Steeve ^a   Nguyen, An ^a  

^a University of Florida   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; AZITHROMYCIN; CEFAZOLIN; CEFTAZIDIME; CEFTIOFUR; CHLORAMPHENICOL; CLARITHROMYCIN; CLINDAMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ENROFLOXACIN; ERYTHROMYCIN; FLORFENICOL; GENTAMICIN; IMIPENEM; NITROFURANTOIN; OXACILLIN; PENICILLIN G; RIFAMPICIN; TETRACYCLINE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; DRUG ACTIVITY; HORSE; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASTEURELLA; PRIORITY JOURNAL; RHODOCOCCUS EQUI; SALMONELLA ENTERICA;

ANIMALS; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CLARITHROMYCIN; HORSES; MICROBIAL SENSITIVITY TESTS; RHODOCOCCUS EQUI;

EID: 0038673368     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.47.5.1742-1745.2003     Document Type: Article

References (25)

1. Adamson, P. J., W. D. Wilson, D. C. Hirsh, J. D. Baggot, and L. D. Martin. 1985. Susceptibility of equine bacterial isolates to antimicrobial agents. Am. J. Vet. Res. 46:447-450.
2. Ainsworth, D. M., S. W. Eicker, A. E. Yeagar, C. R. Sweeney, L. Viel, D. Tesarowski, J. P. Lavoie, A. Hoffman, M. R. Paradis, S. M. Reed, H. N. Erb, E. Davidow, and M. Nalevanko. 1998. Associations between physical examination, laboratory, and radiographic findings and outcome and subsequent racing performance of foals with Rhodococcus equi infection: 115 cases (1984-1992). J. Am. Vet. Med. Assoc. 213:510-515.
3. Arlotti, M., G. Zoboli, G. L. Moseatelli, G. Magnani, R. Maserati, V. Borghi, M. Andreoni, M. Libanore, L. Bonazzi, A. Piscina, and R. Ciammarughi. 1996. Rhodococcus equi infection in HIV-positive subjects: a retrospective analysis of 24 cases. Scand. J. Infect. Dis. 28:463-467.
4. Bowersock, T. L., S. A. Salmon, E. S. Portis, J. F. Prescott, D. A. Robison, C. W. Ford, and J. L. Watts. 2000. MICs of oxazolidinones for Rhodococcus equi strains isolated from humans and animals. Antimicrob. Agents Chemother. 44:1367-1369.
5. Burrows, G. E., R. J. Morton, and W. H. Fale. 1993. Microdilution antimicrobial susceptibilities of selected gram-negative veterinary bacterial isolates. J. Vet. Diagn. Investig. 5:541-547.
6. Davis, J. L., S. Y. Gardner, S. L. Jones, B. A. Schwabenton, and M. G. Papich. 2002. Pharmacokinetics of azithromycin in foals after i.v. and oral dose and disposition into phagocytes. J. Vet. Pharmacol. Ther. 25:99-104.
7. Donisi, A., M. G. Suardi, S. Casari, M. Longo, G. P. Cadeo, and G. Carosi. 1996. Rhodococcus equi infection in HIV-infected patients. AIDS 10:359-362.
8. Ensink, J. M., B. van Klingeren, D. J. Houwers, W. R. Klein, and A. G. Vulto. 1993. In-vitro susceptibility to antimicrobial drugs of bacterial isolates from horses in The Netherlands. Equine Vet. J. 25:309-313.
9. Gavan, T. L., R. N. Jones, and A. L. Barry. 1980. Evaluation of the Sensititre system for quantitative antimicrobial drug susceptibility testing: a collaborative study. Antimicrob. Agents Chemother. 17:464-469.
10. Giacometti, A., O. Cirioni, F. Ancarani, M. S. Del Prete, M. Fortuna, and G. Scalise. 1999. In vitro activities of polycationic peptides alone and in combination with clinically used antimicrobial agents against Rhodococcus equi. Antimicrob. Agents Chemother. 43:2093-2096.
11. Harvey, R. L., and J. C. Sunstrum. 1991. Rhodococcus equi infection in patients with and without human immunodeficiency virus infection. Rev. Infect. Dis. 13:139-145.
12. Hillidge, C. J. 1987. Use of erythromycin-rifampin combination in treatment of Rhodococcus equi pneumonia. Vet. Microbiol. 14:337-342.
13. Hondalus, M. K., and D. M. Mosser. 1994. Survival and replication of Rhodococcus equi in macrophages. Infect. Immun. 62:4167-4175.
14. Jacks, S., S. Giguère, R. Gronwall, M. P. Brown, and K. A. Merritt. 2001. Pharmacokinetics of azithromycin and concentration in body fluids and bronchoalveolar cells in foals. Am. J. Vet. Res. 62:1870-1875.
15. Jacks, S., S. Giguère, R. R. Gronwall, M. P. Brown, and K. A. Merritt. 2002. Disposition of oral clarithromycin in foals. J. Vet. Pharmacol. Ther. 25:359-362.
16. Jones, R. N., T. L. Gavan, and A. L. Barry. 1980. Evaluation of the sensititre microdilution antibiotic susceptibility system against recent clinical isolates: three-laboratory collaborative study. J. Clin. Microbiol. 11:426-429.
17. Lakritz, J., W. D. Wilson, A. E. Marsh, and J. E. Mihalyi. 2000. Pharmacokinetics of erythromycin estolate and erythromycin phosphate after intragastric administration to healthy foals. Am. J. Vet. Res. 61:914-919.
18. Lakritz, J., W. D. Wilson, and J. E. Mihalyi. 1999. Comparison of microbiologic and high-performance liquid chromatography assays to determine plasma concentrations, pharmacokinetics, and bioavailability of erythromycin base in plasma of foals after intravenous or intragastric administration. Am. J. Vet. Res. 60:414-419.
19. National Committee for Clinical Laboratory Standards. 1997. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. 4th ed. NCCLS document M7-A4. 1997. National Committee for Clinical Laboratory Standards, Wayne, Pa.
20. National Committee for Clinical Laboratory Standards. 1999. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals; approved standards. NCCLS document M31-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
21. Nordmann, P., and E. Ronco. 1992. In-vitro antimicrobial susceptibility of Rhodococcus equi. J. Antimicrob. Chemother. 29:383-393.
22. Soriano, F., R. Fernandez-Roblas, R. Calvo, G. Garcia-Calvo, M. Pardeiro, and A. Bryskier. 1998. In-vitro antimicrobial activity of HMR 3004 (RU 64004) against erythromycin A-sensitive and -resistant Corynebacterium spp. isolated from clinical specimens. J. Antimicrob. Chemother. 42:647-649.
23. Stratton-Phelps, M., W. D. Wilson, and I. A. Gardner. 2000. Risk of adverse effects in pneumonic foals treated with erythromycin versus other antibiotics: 143 cases (1986-1996). J. Am. Vet. Med. Assoc. 217:68-73.
24. Sweeney, C. R., R. W. Sweeney, and T. J. Divers. 1987. Rhodococcus equi pneumonia in 48 foals: response to antimicrobial therapy. Vet. Microbiol. 14:329-336.
25. Whitman, M. S., and A. R. Tunkel. 1992. Azithromycin and clarithromycin: overview and comparison with erythromycin. Infect. Control Hosp. Epidemiol. 13:357-368.